RDHLNasdaqManufacturing

RedHill Biopharma Ltd. (RDHL) earnings date, market-implied expected move, and options open interest by expiry

0.42

+0.03 · +7.92%

Regular session15:12 ET

Open0.40Volume109,223Mkt cap$2.0MEPS0.00

Day0.39 – 0.41100%52-wk0.38 – 1.603%

RDHL

RedHill Biopharma Ltd.

OpenVolumeMkt capP/EEPSDiv yield

Day – 52-wk –

Expected move

No implied move.

News

4hRedHill Biopharma: two labs confirm RHB-204 MAP-killing, comparable to RHB-104
52dRedHill (RDHL) Acquires Rebyota and Clenpiq Commercialization Rights for $12M Upfront. Can Sales Outpace Royalties?
62dRedHill Announces Transformational Acquisition of Commercialization Rights to Ferring's Rebyota® and Clenpiq®

News

Next report

Last report

—

Largest filed tie

—

13F top-10 QoQ

−36.95%

shares held · 9 largest managers

13F · Jun 30 '26125d lag

Top fund weight

—

No upcoming report date for RedHill Biopharma (RDHL). No implied move.

Implied vs realized

No reported quarters.

Implied vs realized

Positioning

No open-interest data.

Positioning

Linked exposure

No linked exposure.

Linked exposure

Revenue flow

No filed income statement.

Revenue flow

Intraday

15m bars

Hatch = extended hours · ▯ up · ▮ downSource: market data · 19:45 ET

Intraday

Event sensitivity

PCE ×0.74· ±3.5% vs ±4.7% · 20 releases

eventrelease day|move|up · n×base

PCEpersonal income & outlays±3.5%7 of 20×0.74

FOMCrate decision±3.4%4 of 24×0.72

CPIconsumer prices±3.1%3 of 11×0.66

NFPjobs report±2.8%5 of 10×0.59

GDPgross domestic product±2.5%3 of 20×0.53

PPIproducer prices±2.5%4 of 11×0.53

CPROFcorporate profits±2.0%3 of 12×0.41

Bar = avg |move| to ±5% · tick = ±4.7% avg day · ×base = |move| ÷ ±4.7% · min 6 releases

Earnings history

No reported quarters.

Methodology

ties · implied moves · holdersMethod